Viewing Study NCT06130995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-05 @ 10:40 PM
Study NCT ID: NCT06130995
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2023-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Sponsor: University of Oklahoma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Androgen Deprivation Therapy View
None Locally Advanced Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dose limiting toxicity (DLTs) View
None pathologic complete response (pCR) View
None minimal residual disease (MRD) View
None radiation therapy (RT) View